Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/1173
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKharel, Ranju-
dc.contributor.authorSitaula-
dc.contributor.authorShrestha, Saurav Man-
dc.date.accessioned2023-05-02T06:01:26Z-
dc.date.available2023-05-02T06:01:26Z-
dc.date.issued2021-
dc.identifier.citationKharel (Sitaula)R., & ShresthaS. M. (2021). An Experience with Intravitreal Dexamethasone Implant for Uveitic Macular Oedema. Journal of Nepal Health Research Council, 19(03), 647-649. https://doi.org/10.33314/jnhrc.v19i3.2292en_US
dc.identifier.issnPrint ISSN: 1727-5482; Online ISSN: 1999-6217-
dc.identifier.urihttp://103.69.126.140:8080/handle/20.500.14356/1173-
dc.descriptionCase Reporten_US
dc.description.abstractAbstract Intravitreal steroid implants are the latest trend for uveitis macular oedema treatment. Dexamethasone intravitreal implants are new in our contexts but we report 2 cases of uveitic cystoid macular oedema where this implant proved very useful in the treatment of recalcitrant macular oedema where other treatment modality fails. Two cases of non-infectious uveitis and intermediate uveitis with recalcitrant uveitic macular oedema underwent dexamethasone intravitreal implantation. Their central macular thickness & central macular volume reduced significantly with the implant. With the reduction in macular parameters, the best-corrected visual acuity also improved and visual rehabilitation was achieved. Thus, dexamethasone intravitreal implant helps in sustained drug delivery inside the vitreous leading to resolution of uveitic macular oedema in recalcitrant cases. Keywords: Macular oedema; ozurdex; steroid; uveitis; visionen_US
dc.language.isoenen_US
dc.publisherNepal Health Research Councilen_US
dc.relation.ispartofseriesJuly-Sep, 2021;2292-
dc.subjectMacular oedemaen_US
dc.subjectozurdexen_US
dc.subjectsteroiden_US
dc.subjectuveitisen_US
dc.subjectvisionen_US
dc.titleAn Experience with Intravitreal Dexamethasone Implant for Uveitic Macular Oedemaen_US
dc.typeJournal Articleen_US
local.journal.categoryCase Report-
Appears in Collections:Vol. 19 No. 03 (2021): Vol 19 No 3 Issue 52 Jul-Sep 2021

Files in This Item:
File Description SizeFormat 
2292-Manuscript-25093-1-10-20211215.pdfFulltext Download383.44 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.